EFFECT OF SAIREYAKA CHURNA IN THE TREATMENT OF KAPHAJ YONIVYAPAD

A CLINICAL STUDY OF SAIREYAKA (BARLERIA PRIONITIS ) CHURNA ORALLY IN THE MANAGEMENT OF KAPHAJ YONIVYAPAD - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106995

Enrollment

Registered

2026-03-27

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N738- Other specified female pelvic inflammatory diseases

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Woman after consummation of marriage. Patients fulfilling the diagnostic criteria. Patient willing to go through trial . Age between 18 years to 45 years.

Exclusion criteria

Exclusion criteria: Unmarried woman. pregnant women. Age below 18years and after Menopause Second & third degree Uterine prolapse

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Saireyaka (Barleria prionitis) churna on Kaphaja YonivyapadTimepoint: 60 days	—

Secondary

Measure	Time frame
To identify adverse effects drug, if any have & it will be recorded in ADR (adverse drug reactions) Performa.Timepoint: 60 days	—

Countries

India

Contacts

Public ContactDr Varsha Kunari Gothwal

PGIA JODHPUR

aspneelima@gmail.com9610350131

Outcome results